Position in ABVX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$295,300
New position
Shares Held
2,652
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026GTS SECURITIES LLC holds $7,337,364 across 30 Biotechnology names. ABVX ranks #8 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,738 | $776,086 | |
| 2 | ACLX |
Arcellx, Inc.
|
6,338 | $727,729 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
|
15,604 | $627,748 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
767 | $592,614 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
7,787 | $370,427 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,052 | $348,075 | |
| 7 | INSM |
INSMED Inc
|
1,991 | $325,568 | |
| 8 | ABVX |
Abivax S.A.
This page
|
2,652 | $295,300 |
All Filings in ABVX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $295,300 | 2,652 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||